The Feinstein Institute for Medical Research has earned the 2016 Gold Electrode Award Most Valuable Nonprofit Organization by Neurotech Reports. The Award was given at the 2016 Neurotech Leaders Forum in San Francisco, California, and recognizes the Feinstein Institute for having the vision and the fortitude to drive the bioelectronic medicine field forward, and expand neuromodulation technologies into new indications.
Researchers in the Feinstein Institute’s Center for Bioelectronic Medicine develop device technology to read and modulate the electrical activity within the body’s nervous system, opening new doors to real-time diagnostics and treatment options for patients.
Neurotech Reports is an industry trade publication that provides business and technology professionals information about the field of neurotechnology and future developments that will affect the venture capital, research, and start-up communities.
“We are honored to accept this distinguished honor from Neurotech Reports, a leader in the field,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. “Receiving this recognition illustrates our promising work and that we are on the right path to making new treatments for people facing troubling conditions from rheumatoid arthritis to paralysis.”
About The Feinstein Institute
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 2,000 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.